CVD Prevention Journal Articles

• Statins and Disease Recurrence in Ulcerated Primary Melanoma Might long-term statin use before melanoma diagnosis reduce the risk of melanoma recurrence?
  The British Journal of Dermatology, January 19, 2021
• Transmission of SARS-COV-2 Infections in Households The findings in this report suggest that transmission of SARS-CoV-2 within households is high, occurs quickly, and can originate from both children and adults.
  Morbidity & Mortality Weekly Report, January 11, 2021
• Prevention of Heart Failure in Type 2 Diabetes Mellitus – The Importance of Lifestyle Lifestyle interventions that improve fitness and promote weight loss over the long term can modify heart failure risk in patients with this condition.
  ACC.org, January 06, 2021
• Prognostic Factors for 30-Day Mortality in COVID-19 Patients Could certain factors predict which critically ill COVID-19 patients are at a greater risk for 30-day mortality?
  Critical Care Medicine, January 06, 2021
• Ischemic Stroke Occurs Less Frequently in COVID-19 Patients Anecdotal reports have suggested an increased risk of stroke in patients with COVID-19, but this large cross-sectional study did not find an increased occurrence of stroke in this group.
  Stroke, December 30, 2020
• Sources of High Glycemic Index Foods in Diets of US Children What are the top sources of added sugars and types of high glycemic index foods in diets of U.S. children, and how to they differ by race/ethnicity?
  Preventing Chronic Disease, December 29, 2020
• Evaluating Risk of Dementia in Older People A recent paper presents novel tools to identify people at high risk of developing dementia based on established genetic and lifestyle factors.
  European Heart Journal, December 28, 2020
• Incident T2DM After Initiation of Common HIV ART Drugs How likely are HIV patients to develop prediabetes or type 2 diabetes after ART initiation -- and which drugs are these events associated with?
  AIDS, December 28, 2020
• A Pesco-Mediterranean Diet With Intermittent Fasting Is a pesco-Mediterranean diet combined with time-restricted eating the ideal choice for optimizing cardiovascular health?
  Journal of the American College of Cardiology, December 25, 2020
• Colchicine for Secondary Cardiovascular Disease Prevention Recent studies indicate that colchicine, an inexpensive oral anti-inflammatory medication, can significantly reduce nonfatal cardiovascular events in patients with coronary artery disease.
  Circulation, December 25, 2020
• Towards Nucleic Acid-based Therapies for CVD This paper presents key nucleic acid-based therapeutic strategies for prevention and management of cardiovascular diseases, and their current clinical applications.
  European Heart Journal, December 21, 2020
• Glucosamine/Chondroitin and Mortality in a US NHANES Cohort Does regular consumption of glucosamine/chondroitin have a beneficial impact on overall and cardiovascular mortality?
  Journal of the American Board of Family Medicine, December 15, 2020
• Vericiguat in HFrEF With High Natriuretic Peptides Do some patients have too advanced HF to benefit from vericiguat? A new trial demonstrated that patients with lower baseline NT-proBNP benefited more from vericiguat than those with higher NT-proBNP.
  JACC: Heart Failure, December 11, 2020
• Severe Acute Ischemic Strokes With LVO in COVID-19 Patients This report compared the severity of anterior circulation large vessel occlusion strokes in patients with and without COVID-19, as determined by early brain imaging.
  Stroke, December 09, 2020
• Lifelong Aspirin for All in the Secondary Prevention of CCS? Emerging evidence suggests that reappraisal may be warranted regarding the efficacy of lifelong aspirin in some patients with chronic coronary syndrome.
  Circulation, December 07, 2020
• Muscle Dysfunction in Cushing's Syndrome Despite Remission Cushing syndrome-associated muscle dysfunction may not resolve despite achieving remission, a new study reports.
  Journal of Clinical Endocrinology & Metabolism, December 07, 2020
• Sacubitril/Valsartan: Neprilysin Inhibition 5 Years Later In 2014, the PARADIGM-HF trial determined that sacubitril/valsartan improved outcomes compared to enalapril in patients with chronic HFrEF. What have we learned about neprilysin inhibition since?
  JACC: Heart Failure, December 04, 2020
• Increased CV and Bleeding Risk: The Price for Pain Relief? A new study confirms that NSAID use post-MI significantly increased cardiovascular and bleeding risk.
  Journal of the American College of Cardiology, December 04, 2020
• The Paclitaxel Story in Cardiovascular Medicine A new study examines the safety of paclitaxel-coated stents when used for treatment of femoropopliteal lower extremity artery disease.
  European Heart Journal, November 30, 2020
• Not Even a Peripheral Role for Statins in ESRD? A new editorial explores the question of whether statin therapy offers benefits in the management of end-stage renal disease.
  Nephrology Dialysis Transplantation, November 25, 2020